"At UNC, research is much more than an ivory tower exercise," said Vice Chancellor for Research
Launched in 2006, the NIH-led CTSA program has enabled innovative research teams to speed discovery and advance science aimed at improving the nation's health. Institutional CTSA awards are at the heart of the program, providing academic homes for translational sciences. The program currently supports a consortium of approximately 60 academic medical institutions that is fostering team science, leveraging national resources and transforming the way biomedical research is conducted across the country.
The grant will provide another five years of funding for the North Carolina Translational and Clinical Sciences (NC TraCS) Institute, which is now recognized as the central entity on the
Among its many achievements, NC TraCS provided personalized medicine to 500 North Carolinians across 56 counties who participated in a trial that looked at the impact of a gene variant on the recurrence of breast cancer. The work led to an intervention in which patients received an adjusted chemotherapy dose based on their results.
A smaller project called "Research on Location" helped recruit Spanish-speaking women from one N.C. church and two community health centers across two counties to participate in a pilot study to manage weight gain and prevent type 2 diabetes.
"The goal and mission of NC TraCS will continue to enable investigators, research units and academic programs to be even more successful in making lives better in our state's communities," said
To increase its impact and scope over the next five years, NC TraCS is expanding its integrated home on campus to include
"We have a large and diverse portfolio of health research, spanning the continuum of clinical and translational science," said
The partnership with N.C. A&T will give
"Together, we will develop a robust pipeline of minority clinical and translational research scientists in a manner that can be a model for the nation," said Barry L. Burks, N.C. A&T's vice chancellor for research and economic development.
The three institutions will leverage their strengths to pursue and focus on three strategic initiatives:
* Next-generation technologies to transform the nature of clinical research and practice
* Robust comparative effectiveness studies to provide definitive evidence of the benefits and or harms of tests and treatments
* New paradigms and resources to accelerate drug development
TNS 30TagarumaMar-131026-4528854 30TagarumaMar
Most Popular Stories
- 2014 Will Be 'Breakthrough Year' for U.S., Obama Says
- Target Overwhelmed by Worried Customers
- Congress Ends Turbulent Year with Approving IRS Chief
- First Family Arrives for Hawaiian Island Holiday
- Covered California Lags on Hispanic Enrollment
- Renewable Energy Group to Acquire Syntroleum
- Ally Financial Settles Auto Loan Suit
- Climate Change Isn't an Equal Opportunity Destroyer
- Kanye, Kardashians and Other Kooks: A Wacky, Tacky, Entertaining Year
- Luis Suarez Re-ups With Liverpool F.C.